118 related articles for article (PubMed ID: 25124196)
1. [Prevalence of uterine fibroids in France and impact on quality of life: results of a survey among 2500 women between 30-55 years].
Fernandez H; Chabbert Buffet N; Allouche S
J Gynecol Obstet Biol Reprod (Paris); 2014 Nov; 43(9):721-7. PubMed ID: 25124196
[TBL] [Abstract][Full Text] [Related]
2. Utility values for pre-menopausal women suffering from symptomatic uterine fibroids.
Hux M; Ng C; Ortega GL; Ferrazzi S; Goeree R
Expert Rev Pharmacoecon Outcomes Res; 2015 Feb; 15(1):181-9. PubMed ID: 25284595
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound-guided radiofrequency ablation of symptomatic uterine fibroids: short-term evaluation of effect of treatment on quality of life and symptom severity.
Iversen H; Lenz S; Dueholm M
Ultrasound Obstet Gynecol; 2012 Oct; 40(4):445-51. PubMed ID: 22378629
[TBL] [Abstract][Full Text] [Related]
4. Impact of uterine fibroids on quality of life: a national cross-sectional survey.
Hervé F; Katty A; Isabelle Q; Céline S
Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():32-37. PubMed ID: 30099225
[TBL] [Abstract][Full Text] [Related]
5. [Epidemiological data for uterine fibroids in France in 2010-2012 in medical center--analysis from the French DRG-based information system (PMSI)].
Fernandez H; Chabbert-Buffet N; Koskas M; Nazac A
J Gynecol Obstet Biol Reprod (Paris); 2014 Oct; 43(8):616-28. PubMed ID: 25017711
[TBL] [Abstract][Full Text] [Related]
6. Vaginal mifepristone for the treatment of symptomatic uterine leiomyomata: an open-label study.
Yerushalmi GM; Gilboa Y; Jakobson-Setton A; Tadir Y; Goldchmit C; Katz D; Seidman DS
Fertil Steril; 2014 Feb; 101(2):496-500. PubMed ID: 24220703
[TBL] [Abstract][Full Text] [Related]
7. Long-term quality of life assessment among patients undergoing uterine fibroid embolization.
Popovic M; Berzaczy D; Puchner S; Zadina A; Lammer J; Bucek RA
AJR Am J Roentgenol; 2009 Jul; 193(1):267-71. PubMed ID: 19542423
[TBL] [Abstract][Full Text] [Related]
8. Clinical long-term outcome after uterine artery embolization: sustained symptom control and improvement of quality of life.
Scheurig-Muenkler C; Koesters C; Powerski MJ; Grieser C; Froeling V; Kroencke TJ
J Vasc Interv Radiol; 2013 Jun; 24(6):765-71. PubMed ID: 23582992
[TBL] [Abstract][Full Text] [Related]
9. Fibroid volume, location and symptoms in women undergoing uterine artery embolization: does size or position matter?
Arleo EK; Masheb RM; Pollak J; McCarthy S; Tal MG
Int J Fertil Womens Med; 2007; 52(2-3):111-20. PubMed ID: 18320870
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women.
Zimmermann A; Bernuit D; Gerlinger C; Schaefers M; Geppert K
BMC Womens Health; 2012 Mar; 12():6. PubMed ID: 22448610
[TBL] [Abstract][Full Text] [Related]
11. Initial experience of uterine fibroid embolization using porous gelatin sponge particles.
Katsumori T; Kasahara T; Oda M; Kotani T
Cardiovasc Intervent Radiol; 2011 Jun; 34(3):513-21. PubMed ID: 20574795
[TBL] [Abstract][Full Text] [Related]
12. Impact of diagnosis and treatment of uterine fibroids on quality of life and labor productivity: The Japanese online survey for uterine fibroids and quality of life (JOYFUL survey).
Koga K; Fukui M; Fujisawa M; Suzukamo Y
J Obstet Gynaecol Res; 2023 Oct; 49(10):2528-2537. PubMed ID: 37524334
[TBL] [Abstract][Full Text] [Related]
13. Environmental exposure and risk of uterine leiomyoma: an epidemiologic survey.
Shen Y; Xu Q; Xu J; Ren ML; Cai YL
Eur Rev Med Pharmacol Sci; 2013 Dec; 17(23):3249-56. PubMed ID: 24338469
[TBL] [Abstract][Full Text] [Related]
14. A US population-based study of uterine fibroid diagnosis incidence, trends, and prevalence: 2005 through 2014.
Yu O; Scholes D; Schulze-Rath R; Grafton J; Hansen K; Reed SD
Am J Obstet Gynecol; 2018 Dec; 219(6):591.e1-591.e8. PubMed ID: 30291840
[TBL] [Abstract][Full Text] [Related]
15. Validation of the UFS-QOL-hysterectomy questionnaire: modifying an existing measure for comparative effectiveness research.
Coyne KS; Margolis MK; Murphy J; Spies J
Value Health; 2012; 15(5):674-9. PubMed ID: 22867776
[TBL] [Abstract][Full Text] [Related]
16. [Change in health-related quality of life and change in clinical symptoms after uterine artery embolization in patients with symptomatic adenomyosis uteri - evaluation using a standardized questionnaire].
Froeling V; Scheurig-Muenkler C; Steffen IG; Schreiter NF; Kröncke TJ
Rofo; 2012 Jan; 184(1):48-52. PubMed ID: 22161234
[TBL] [Abstract][Full Text] [Related]
17. Uterine artery embolization for severe symptomatic fibroids: effects on fertility and symptoms.
Torre A; Paillusson B; Fain V; Labauge P; Pelage JP; Fauconnier A
Hum Reprod; 2014 Mar; 29(3):490-501. PubMed ID: 24430777
[TBL] [Abstract][Full Text] [Related]
18. Mid- and long-term quality-of-life assessment in patients undergoing uterine fibroid embolization.
Bucek RA; Puchner S; Lammer J
AJR Am J Roentgenol; 2006 Mar; 186(3):877-82. PubMed ID: 16498124
[TBL] [Abstract][Full Text] [Related]
19. Treatment failure after uterine artery embolization: prospective cohort study with multifactorial analysis of possible predictors of long-term outcome.
Scheurig-Muenkler C; Koesters C; Grieser C; Hamm B; Kroencke TJ
Eur J Radiol; 2012 May; 81(5):e727-31. PubMed ID: 22381440
[TBL] [Abstract][Full Text] [Related]
20. Long-term medical management of uterine fibroids with ulipristal acetate.
Donnez J; Donnez O; Matule D; Ahrendt HJ; Hudecek R; Zatik J; Kasilovskiene Z; Dumitrascu MC; Fernandez H; Barlow DH; Bouchard P; Fauser BC; Bestel E; Loumaye E
Fertil Steril; 2016 Jan; 105(1):165-173.e4. PubMed ID: 26477496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
